サンプル依頼リスト カート
  • English
  • Korean
表紙：バイオバーデン試験の世界市場規模：用途別、エンドユーザー別、地域別の予測（2022年～2028年）
市場調査レポート
商品コード
1073680

バイオバーデン試験の世界市場規模：用途別、エンドユーザー別、地域別の予測（2022年～2028年）

Global Bioburden Testing Market Size study, by Application (Raw Material, In-Process), by End-Use (Pharmaceutical, Biotechnology, CMO) and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
バイオバーデン試験の世界市場規模：用途別、エンドユーザー別、地域別の予測（2022年～2028年）
出版日: 2022年04月30日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオバーデン試験の市場規模は、2022年～2028年の予測期間中に健全な成長率で成長すると予想されています。

市場成長の主な要因は、人口の増加、製薬分野の成長、医療機器分野の成長です。また、食品・飲料の安全性に対する懸念の高まりによるバイオバーデン試験の導入と需要が、予測期間中の市場成長を後押しすると予想されます。一方で、微生物定量検査機器の高コストが、予測期間中の市場成長の妨げとなっています。

当レポートでは、世界のバイオバーデン試験市場について調査分析し、市場動向、業界分析、COVID-19の影響、セグメント別・地域別の市場分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のバイオバーデン試験市場の定義と範囲

第3章 世界のバイオバーデン試験市場力学

  • バイオバーデン試験市場の影響分析（2020年～2028年）

第4章 世界のバイオバーデン試験市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨と結論
  • 主要投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的影響の評価
    • COVID-19前・COVID-19後の市場シナリオ

第6章 世界のバイオバーデン試験市場：用途別

  • 市場スナップショット
  • 実績 - 潜在性分析
  • 推計と予測（2019年～2028年）
  • サブセグメント分析
    • 原材料
    • インプロセス

第7章 世界のバイオバーデン試験市場：エンドユーザー別

  • 市場スナップショット
  • 実績 - 潜在性分析
  • 推計と予測（2019年～2028年）
  • サブセグメント分析
    • 製薬
    • バイオテクノロジー
    • CMO

第8章 世界のバイオバーデン試験市場：地域別の分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の地域

第9章 競合他社情報

  • 主要市場戦略
  • 企業プロファイル
    • ATS Labs Inc
    • Charles River Laboratories International Inc.
    • Sigma-Aldrich Corporation
    • SGS S.A.
    • Wuxi Pharmatech(CAYMAN)Inc.
    • Merck & Co. Inc.
    • Becton, Dickinson, and Company
    • North American Science Associates Inc.
    • Nelson Laboratories Inc.
    • Pacific Biolabs

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Bioburden Testing market, report scope
  • TABLE 2. Global Bioburden Testing market estimates & forecasts by Region 2019-2028 (USD Billion)
  • TABLE 3. Global Bioburden Testing market estimates & forecasts by Application 2019-2028 (USD Billion)
  • TABLE 4. Global Bioburden Testing market estimates & forecasts by End-Use 2019-2028 (USD Billion)
  • TABLE 5. Global Bioburden Testing market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 6. Global Bioburden Testing market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 7. Global Bioburden Testing market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 8. Global Bioburden Testing market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 9. Global Bioburden Testing market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 10. Global Bioburden Testing market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 11. Global Bioburden Testing market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 12. Global Bioburden Testing market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 13. Global Bioburden Testing market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 14. Global Bioburden Testing market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 15. U.S. Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 16. U.S. Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 17. U.S. Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 18. Canada Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 19. Canada Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 20. Canada Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 21. UK Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 22. UK Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 23. UK Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 24. Germany Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 25. Germany Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 26. Germany Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 27. RoE Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 28. RoE Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 29. RoE Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 30. China Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 31. China Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 32. China Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 33. India Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 34. India Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 35. India Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 36. Japan Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 37. Japan Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 38. Japan Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 39. RoAPAC Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 40. RoAPAC Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 41. RoAPAC Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 42. Brazil Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 43. Brazil Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 44. Brazil Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 45. Mexico Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 46. Mexico Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 47. Mexico Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 48. RoLA Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 49. RoLA Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 50. RoLA Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 51. Row Bioburden Testing market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 52. Row Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 53. Row Bioburden Testing market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 54. List of secondary sources, used in the study of global Bioburden Testing market
  • TABLE 55. List of primary sources, used in the study of global Bioburden Testing market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Bioburden Testing market, research methodology
  • FIG 2. Global Bioburden Testing market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Bioburden Testing market, key trends 2021
  • FIG 5. Global Bioburden Testing market, growth prospects 2022-2028
  • FIG 6. Global Bioburden Testing market, porters 5 force model
  • FIG 7. Global Bioburden Testing market, pest analysis
  • FIG 8. Global Bioburden Testing market, value chain analysis
  • FIG 9. Global Bioburden Testing market by segment, 2019 & 2028 (USD Billion)
  • FIG 10. Global Bioburden Testing market by segment, 2019 & 2028 (USD Billion)
  • FIG 11. Global Bioburden Testing market by segment, 2019 & 2028 (USD Billion)
  • FIG 12. Global Bioburden Testing market by segment, 2019 & 2028 (USD Billion)
  • FIG 13. Global Bioburden Testing market by segment, 2019 & 2028 (USD Billion)
  • FIG 14. Global Bioburden Testing market, regional snapshot 2019 & 2028
  • FIG 15. North America Bioburden Testing market 2019 & 2028 (USD Billion)
  • FIG 16. Europe Bioburden Testing market 2019 & 2028 (USD Billion)
  • FIG 17. Asia pacific Bioburden Testing market 2019 & 2028 (USD Billion)
  • FIG 18. Latin America Bioburden Testing market 2019 & 2028 (USD Billion)
  • FIG 19. Global Bioburden Testing market, company market share analysis (2021)
目次

Global Bioburden Testing Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Bioburden Testing is a process of measuring viable microorganisms on medical devices, raw materials, or packages. The process helps in determining parameters for its sterilization process to ensure the safety and effectiveness of medical devices. The growth in medical devices along with the rising population, growing pharmaceutical sector has led to the adoption of Bioburden Testing across the forecast period. For Instance: as per the IBEF, India is among the top 20 markets for medical devices worldwide. The market is expected to increase at a 37% CAGR to reach US$ 50 billion in 2025, from Rs. 75,611 crore (US$ 10.36 billion) in 2020. The medical devices sector in India comprises large multinationals and small and mid-sized companies. Also, with the increasing food & beverage safety concerns, the adoption & demand for Bioburden Testing is likely to increase the market growth during the forecast period. However, high cost of microbial enumeration instruments impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Bioburden Testing market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to the increasing food & beverage safety concerns. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as rising disposable income, increasing preference for contract manufacturing and growing population would create lucrative growth prospects for the Bioburden Testing market across Asia-Pacific region.

Major market players included in this report are:

ATS Labs Inc

Charles River Laboratories International Inc.

Sigma-Aldrich Corporation

SGS S.A.

Wuxi Pharmatech (CAYMAN) Inc.

Merck & Co. Inc.

Becton, Dickinson, and Company

North American Science Associates Inc.

Nelson Laboratories Inc.

Pacific Biolabs

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

Raw Material

In-Process

By End Use:

Pharmaceutical

Biotechnology

CMO

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Bioburden Testing Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Global Bioburden Testing Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Global Bioburden Testing Market, by Application, 2020-2028 (USD Billion)
    • 1.2.3. Global Bioburden Testing Market, by End-Use, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Bioburden Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Bioburden Testing Market Dynamics

  • 3.1. Bioburden Testing Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growth in the medical devices with rising population
      • 3.1.1.2. Growing pharmaceutical sector
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of microbial enumeration instruments
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing food & beverage safety concerns

Chapter 4. Global Bioburden Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Bioburden Testing Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Bioburden Testing Market by Application, Performance - Potential Analysis
  • 6.3. Global Bioburden Testing Market Estimates & Forecasts by Application, 2019-2028 (USD Billion)
  • 6.4. Bioburden Testing Market, Sub Segment Analysis
    • 6.4.1. Raw Material
    • 6.4.2. In-Process

Chapter 7. Global Bioburden Testing Market, by End-Use

  • 7.1. Market Snapshot
  • 7.2. Global Bioburden Testing Market by End-Use, Performance - Potential Analysis
  • 7.3. Global Bioburden Testing Market Estimates & Forecasts by End-Use, 2019-2028 (USD Billion)
  • 7.4. Bioburden Testing Market, Sub Segment Analysis
    • 7.4.1. Pharmaceutical
    • 7.4.2. Biotechnology
    • 7.4.3. CMO

Chapter 8. Global Bioburden Testing Market, Regional Analysis

  • 8.1. Bioburden Testing Market, Regional Market Snapshot
  • 8.2. North America Bioburden Testing Market
    • 8.2.1. U.S. Bioburden Testing Market
      • 8.2.1.1. Application breakdown estimates & forecasts, 2019-2028
      • 8.2.1.2. End-Use breakdown estimates & forecasts, 2019-2028
    • 8.2.2. Canada Bioburden Testing Market
  • 8.3. Europe Bioburden Testing Market Snapshot
    • 8.3.1. U.K. Bioburden Testing Market
    • 8.3.2. Germany Bioburden Testing Market
    • 8.3.3. France Bioburden Testing Market
    • 8.3.4. Spain Bioburden Testing Market
    • 8.3.5. Italy Bioburden Testing Market
    • 8.3.6. Rest of Europe Bioburden Testing Market
  • 8.4. Asia-Pacific Bioburden Testing Market Snapshot
    • 8.4.1. China Bioburden Testing Market
    • 8.4.2. India Bioburden Testing Market
    • 8.4.3. Japan Bioburden Testing Market
    • 8.4.4. Australia Bioburden Testing Market
    • 8.4.5. South Korea Bioburden Testing Market
    • 8.4.6. Rest of Asia Pacific Bioburden Testing Market
  • 8.5. Latin America Bioburden Testing Market Snapshot
    • 8.5.1. Brazil Bioburden Testing Market
    • 8.5.2. Mexico Bioburden Testing Market
  • 8.6. Rest of The World Bioburden Testing Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. ATS Labs Inc
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Charles River Laboratories International Inc.
    • 9.2.3. Sigma-Aldrich Corporation
    • 9.2.4. SGS S.A.
    • 9.2.5. Wuxi Pharmatech (CAYMAN) Inc.
    • 9.2.6. Merck & Co. Inc.
    • 9.2.7. Becton, Dickinson, and Company
    • 9.2.8. North American Science Associates Inc.
    • 9.2.9. Nelson Laboratories Inc.
    • 9.2.10. Pacific Biolabs

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption